Off-Label Coverage Issues
CMS continue to provide coverage for the two approved compendia from statute. CMS may introduce guidelines for any new compendium seeking recognition in a proposed rule this year.
- Update on the Nine CMS/NCI-Sponsored Clinical Trials of Four Colorectal Drugs
- CMS Issues Final NCD for Anticancer Chemotherapy for Colorectal Cancer
Matt Farber, Manager, Provider Economics & Public Policy,Phone 301.984.9496, ext. 221, Email mfarber@accc-cancer.org
